Investing Profile

Wende Hutton

VCInvestor

General Partner at Canaan

canaan.com/team/wende-huttonMenlo Park, California

Your Intro Paths to Wende Hutton

Signal uses Gmail to reveal intro paths. Email content is never read.

Networks Wende is a member of

Moving Capital Network

962 CONNECTIONS

Moving Capital Network

962 CONNECTIONS

Canaan Network

40 CONNECTIONS

Mayfield Network

37 CONNECTIONS

Find Wende Hutton on

Current Investing Position

Canaan Partners General Partner

Investment Range

$250K - $20.0M

Sweet Spot

$10.0M

Investments On Record

Current Fund Size

$800M

Wende Hutton is on these Sector & Stage Rankings

Pharmaceuticals (Seed)BioTech (Seed)BioTech (Series A)Health IT (Series A)Pharmaceuticals (Series A)Diverse Investors Female Investors Health & Hospital Services (Series A)San Francisco Bay Area Health IT (Seed)Health & Hospital Services (Seed)

Wende Hutton's Investments On Record (20)

Company	StageDateRound Size	Total Raised
Glooko	Series FOct 2024$100M Series DMar 2021$30M Series CJun 2017$35M Series CSep 2016$8M Series BMar 2015$17M	$200M
Co-investors: Ted Maidenberg (U.S. Venture Partners (USVP)), Venky Harinarayan (rocketship.vc), Chamath Palihapitiya (Social Capital LP), Bill Campbell (Crossfade Partners), Sundeep Madra (Ford Motor Company), David Carrico (Focus Investments), Anand Rajaraman (Milliways Ventures)
Qlaris Bio	Series BApr 2024$24M Series AAug 2019$25M	$49M
OncoResponse	Series DMay 2023$14M Series CMar 2021$41M Series BSep 2018$40M Series AMay 2016$13M	$110M
Co-investors: John McKearn (RiverVest Venture Partners)
Antiva Biosciences	Series EApr 2023$53M Series DNov 2021$31M Series CJul 2018$15M Series CMar 2017$22M Series BAug 2015$16M	$140M
Co-investors: Jenny Yip (Adjuvant Capital)
MoCaFi	Series AFeb 2021$12M	$40M
Co-investors: Dan Rosen (Commerce Ventures), Karen Kerr (GE Ventures), Thompson Hutton (Genstar Capital), Lorine Pendleton (125 Ventures)
Hyalex Orthopaedics	Series AMar 2019$17M Series AMay 2017$16M	$33M
Co-investors: Bill Harrington (Osage University Partners (OUP)), V.Kadir Kadhiresan (Johnson & Johnson Innovation), Renee Compton Ryan (Johnson & Johnson Innovation)
ReVision Optics	Series UnknownNov 2016$32M Series EJul 2013$55M Series EApr 2013$15M Series DJul 2010$35M Series CJun 2006$3M Series COct 2005$12M Series CDec 2004$5M	$180M
Co-investors: Brian Dovey (Domain Associates), Bruce Cleveland (Obo), Gil Kliman (InterWest), Reza Zadno (Avedro, Inc.), Renee Compton Ryan (Johnson & Johnson Innovation)
Chrono Therapeutics	Series BSep 2016$48M Series AJun 2014$32M	$80M
Co-investors: James Young (Hotmail), Liz Rockett (Kaiser Permanente Ventures)

Wende Hutton's Experience

Director, International Business Unit; Dir of Business Development; Marketing NellcorPresent

General Manager, Transgenic Lab Products Moving CapitalPresent

supporter Moving CapitalPresent

General Partner MayfieldPresent

General Partner CanaanPresent

Investors who invest with Wende Hutton

Scouts & Angels Affiliated With Wende Hutton